Fate Therapeutics selected for FDA manufacturing pilot program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. ACN
5. IBM
6. SPY
7. NVDA
8. PRIM
9. PFE
10. TSLA

Go back to Fate Therapeutics selected for FDA manufacturing pilot program
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.17 +0.02 (0.93%)
Previous Close $2.15    52 Week High $4.76 
Open $2.10    52 Week Low $1.46 
Day High $2.32    P/E N/A 
Day Low $2.10    EPS $-1.91 
Volume 1,477,990